Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17291661)

Published in Prog Neuropsychopharmacol Biol Psychiatry on January 16, 2007

Authors

Mercedes Zumárraga1, Ricardo Dávila, Miguel Angel González-Torres, Juan B Anguiano, María José Zabalo, Nieves Basterreche, Aurora Arrúe, María Isabel Zamalloa, José Guimón

Author Affiliations

1: Departamento de Investigación Neuroquímica, Hospital Psiquiátrico de Zamudio, Servicio Vasco de Salud (Osakidetza), Arteaga Auzoa, 45, E-48170 Zamudio, Vizcaya, Spain.

Articles by these authors

Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacology (2003) 0.91

Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology (2004) 0.86

Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Brain Res Mol Brain Res (2003) 0.85

GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients. Neurochem Res (2009) 0.85

Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int J Pharm (2007) 0.82

The economic crisis in Spain and its impact on the mental health of children and adolescents. Eur Child Adolesc Psychiatry (2013) 0.80

Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain. Neuropsychopharmacology (2002) 0.79

G protein-coupled receptor kinases, beta-arrestin-2 and associated regulatory proteins in the human brain: postmortem changes, effect of age and subcellular distribution. Brain Res Mol Brain Res (2002) 0.78

The influence of the Val158Met catechol-O-methyltransferase polymorphism on the personality traits of bipolar patients. PLoS One (2013) 0.78

Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int (2010) 0.76

Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test. Neurochem Res (2011) 0.76

Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder. Neuropsychobiology (2008) 0.76

Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms. Psychiatry Res (2007) 0.76

Plasma variations in stress markers: clinical trial of two anesthetics used in regional block in the extraction of impacted inferior third molars. Med Oral Patol Oral Cir Bucal (2014) 0.75

Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report. J Affect Disord (2006) 0.75

Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients. Pharmacol Res (2008) 0.75

[Why don't we talk about negative psychotic symptoms in affective bipolar disorder?]. Rev Psiquiatr Salud Ment (2012) 0.75